Trade EW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Edwards Lifesciences Corp (EW) is trading at US$84.37, down 2.77% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$51.75B. Over the past 52 weeks, EW has traded between US$72.30 and US$96.29. On Syfe you can trade EW with $0 commission and add it to your watchlist.
| Previous close | US$86.77 |
|---|---|
| Market cap | US$51.75B |
| P/E ratio | 25.79 |
| 52-week range | US$72.30 – US$96.29 |
| Volume | 3.8M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Edwards Lifesciences Corp
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Year: 2000
Edwards Lifesciences Corp (EW) stock is trading at US$84.37, -2.77% from the previous close of US$86.77.
The market cap for Edwards Lifesciences Corp (EW) stock is approximately US$51.75B.
The price-to-earnings ratio for Edwards Lifesciences Corp (EW) is 25.79, based on the latest reported earnings.
The 52-week high for Edwards Lifesciences Corp (EW) stock is US$96.29.
The 52-week low for Edwards Lifesciences Corp (EW) stock is US$72.30.
Edwards Lifesciences Corp (EW) does not currently pay a dividend.
Stay on top of EW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
